Saturday November 21 2009 | Biotechnology feed | All feeds
|
|
Afferon Corporation
Download detailed PDF Members: Afferon is a privately held pharmaceutical company building a specialty pharmaceutical business focused on urology. Afferon has completed the necessary pre-clinical work on its lead candidate, resiniferatoxin, and has shown proof of principle in Phase I/IIa human clinical trials in urinary urge incontinence and diabetic neuropathy pain. Several large Phase II trials are underway in the U.S. and Europe.
This page has been viewed 1205 times since April 2007, the link to the organisation's website has been followed 257 times Recent Search Terms used to find this page: Afferon Corporation | afferon corporation | Afferon Corp | afferon corp | Afferon Corp | Afferon | afferon | Afferon Corp | Afferon | Afferon corporation | . Search for more companies in Wayne Search for more companies in PA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Afferon Corporation | ||||||||||||||||||||||||||
|